Comparison of VEGF and p53 protein expression in stage I non-small cell lung cancer

Japanese Journal of Lung Cancer

Volumn 40, Issue 1, 2000, Pages 11-15

  Odaka, Makoto ^a   Sato, Syuji ^a   Masubuchi, Masataka ^a   Suzuki, Hideyuki ^a   Hirano, Jun ^a   Asakura, Jun ^a   Yamashita, Makoto ^a   Miyoshi, Isao ^a   Akiba, Tadashi ^a   Yamazaki, Yoji ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Non small cell lung cancer; p53; VEGF

Indexed keywords

PROTEIN P53; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME;

EID: 0034079737     PISSN: 03869628     EISSN: None     Source Type: Journal    
DOI: 10.2482/haigan.40.11     Document Type: Article

References (14)

1. van Meir E, Polverini P, Chazin V : Release of an inhibitor of angiogenesis upon induction to wild-type p53 expression in glioblastoma cells. Nature 8 : 171-176, 1994.
2. Toi M, Taniguchi T, Yamamoto Y, et al : Clinical significance of the determination of angiogenic factors. Eur J Cancer 32A : 2513-2519, 1996.
3. Gasparini G, Toi M, Gion M, et al : Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 89 : 139-147, 1997.
4. Fontanini G, Vignati S, Lucchi M, et al : Neoangiogenesis and p53 protein in lung cancer : Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. Br J Cancer 75 : 1295-1301, 1997.
5. Mattern M, Koomagi R, Volm M, et al : Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma. Br J Cancer 73 : 931-934, 1996.
6. Fontanini G, Vignati S, Bigini D, et al : bcl-2 protein : a prognostic factor inversely correlated to p53 in non-small cell lung cancer. Br J Cancer 71 : 1003-1007, 1995.
7. McLaren R, Kuzu I, Dunnill M, et al : The relationship of p 53 immunostaining to survival in carcinoma of the lung. Br J Cancer 66 : 735-738, 1992.
8. Lee JS, Yoon A, Kalapurakal SK, et al : Expression of p53 oncoprotein in non-small cell lung cancer : a favorable prognostic factor. J Clin Oncol 13 : 1893-1903, 1995.
9. Nishino M, Koshikawa T, Kuroishi T, et al : Prognostic significance of abnormal p53 accumulation in primary, resected non-small cell lung cancers. J Clin Oncol 14 : 497-502, 1996.
10. Volm M, Efferth T, Mattern J : Oncoprotein (c-myc, c-erbB 1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinoma of the lung. Clinical and biological correlations. Anticancer Res 12 : 11-20, 1992.
11. Dameron K, Volpert O, Tainsky M : Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265 : 1582-1584, 1994.
12. Mukhopadhyay D, Tsiokas L, Sukhatme V : Wild-type p53 and v-src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 55 : 6161-6165, 1995.
13. Kang SM, Maeda K, Onoda N : Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int J Cancer 74 : 502-507, 1997.